
The average Amneal Pharmaceuticals Investor Relations in Boulder earns an estimated $84,597 annually. Amneal Pharmaceuticals' Investor Relations compensation is $2,666 more than the US average for a Investor Relations.
Last updated 3 months ago.
The majority of Investor Relations at Amneal Pharmaceuticals believe they're compensated fairly. The vast majority (75%) of Investor Relations at Amneal Pharmaceuticals are satisfied with their benefits. See more compensation ratings at Amneal Pharmaceuticals